Physician profile
Kevin Yee
NPI 1487151445
$6,695.73
in general payments reported to CMS, 2019-2025
28 companies · $1,782 in 2025
The $1,782 reported for 2025 was more than what 81% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,241 · 2022: $1,660 · 2023: $1,571 · 2024: $442 · 2025: $1,782.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,163 · Travel and Lodging: $1,632.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,163.35 |
| Travel and Lodging | $1,631.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,892.52 | 2021-2025 | Prostep, Asnis, Easyfuse |
| Treace Medical Concepts, INC. | $1,292.82 | 2022-2025 | |
| Paragon 28, INC. | $921.05 | 2023 | Portfolio, Phantom Metatarsal Shortening, Phantom Intramedullary Nail |
| Integra Lifesciences Corporation | $415.00 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Paratek Pharmaceuticals, INC. | $372.55 | 2021-2025 | Nuzyra |
| Medical Device Business Services, INC. | $321.99 | 2021 | |
| Smith+Nephew, INC. | $261.53 | 2022-2025 | Grafix Pl, Regranex, Collagenase Santyl |
| Organogenesis INC. | $207.73 | 2021-2022 | |
| Osteomed LLC | $146.29 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $145.62 | 2022-2025 | Jublia |
| Zimmer Biomet Holdings, INC. | $134.08 | 2022 | |
| Nabriva Therapeutics, Plc | $55.59 | 2021-2022 | |
| Abbvie INC. | $49.61 | 2021 | |
| Globus Medical, INC. | $48.45 | 2023 | Ankle Fracture System |
| Nevro Corp. | $48.22 | 2022-2024 | Senza |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $47.64 | 2022-2023 | Exogen Ultrasound Bone Healing System |
| Amgen INC. | $45.42 | 2024 | Krystexxa |
| Medtronic, INC. | $43.58 | 2022-2025 | Inceptiv |
| Musculoskeletal Transplant Foundation INC. | $35.87 | 2025 | |
| Sebela Pharmaceuticals INC. | $35.05 | 2023 | Naftin |
| Convatec INC. | $32.91 | 2023 | |
| Depuy Synthes Sales INC. | $30.47 | 2021-2025 | Motoband |
| Kerecis Limited | $29.60 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Davol INC. | $26.49 | 2024 | Arista Ah Flexitip |
| Seapearl East, INC | $20.41 | 2024 | |
| Averitas Pharma INC. | $14.57 | 2024 | Qutenza |
| Alfasigma USA, INC. | $12.66 | 2021 | |
| Orthofix Medical, INC. | $8.01 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Yee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.